CIK 1482416
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 54.83% | 46 |
| Health Care Equipment & Supplies | 16.17% | 12 |
| Commercial Services & Supplies | 8.59% | 2 |
| Software & IT Services | 5.71% | 2 |
| Unclassified | 5.50% | 7 |
| Distributors | 4.57% | 1 |
| Health Care Providers & Services | 3.19% | 1 |
| Life Sciences Tools & Services | 1.34% | 1 |
| Technology Hardware & Equipment | 0.11% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | MMS | MAXIMUS, INC. | Industrials | 7.10% |
| 2 | WAY | Waystar Holding Corp. | Information Technology | 5.71% |
| 3 | ICLR | ICON PLC | Unclassified | 4.89% |
| 4 | COR | Cencora, Inc. | Consumer Discretionary | 4.57% |
| 5 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Health Care | 4.48% |
| 6 | AVR | Anteris Technologies Global Corp. | Health Care | 4.31% |
| 7 | CORT | CORCEPT THERAPEUTICS INC | Health Care | 3.92% |
| 8 | LIVN | LivaNova PLC | Health Care | 3.86% |
| 9 | TYRA | Tyra Biosciences, Inc. | Health Care | 3.34% |
| 10 | CELC | Celcuity Inc. | Health Care | 3.19% |
66/73 names classified · sector 94.5% of weight · industry 94.5% · mkt cap 86.7%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 94.5% of the book is sector-classified (unclassified names shown, never dropped).
Only 36% of book weight classified — the grid is NOT representative of the whole book.
Classified: 35.9% of book weight (13/72 names) · unclassified 64.1%: ICLR, DNTH, AVR, LIVN, TYRA, CELC, GSK, ABVX, VIR, SION +49 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | MMSMAXIMUS INC | 768,825 | $49M | 7.1% | ADD 54% |
| 2 | WAYWAYSTAR HLDG CORP | 1,642,236 | $40M | 5.7% | ADD 168% |
| 3 | ICLRICON PLC | 306,358 | $34M | 4.9% | ADD 141% |
| 4 | CORCENCORA INC | 100,894 | $32M | 4.6% | ADD 535% |
| 5 | DNTHDIANTHUS THERAPEUTICS INC | 370,045 | $31M | 4.5% | TRIM −22% |
| 6 | AVRANTERIS TECHNOLOGIES GLOBAL | 5,382,965 | $30M | 4.3% | ADD 187% |
| 7 | CORTCORCEPT THERAPEUTICS INC | 674,759 | $27M | 3.9% | NEW |
| 8 | LIVNLIVANOVA PLC | 421,615 | $27M | 3.9% | ADD 31% |
| 9 | TYRATYRA BIOSCIENCES INC | 605,439 | $23M | 3.3% | ADD 15% |
| 10 | CELCCELCUITY INC | 193,843 | $22M | 3.2% | TRIM −59% |
| 11 | GSKGSK PLC | 385,879 | $21M | 3.1% | NEW |
| 12 | ANIPANI PHARMACEUTICALS INC | 265,543 | $20M | 2.9% | ADD 204% |
| 13 | ABTABBOTT LABS | 186,574 | $19M | 2.8% | NEW |
| 14 | EMBCEMBECTA CORP | 1,847,850 | $16M | 2.4% | NEW |
| 15 | ABVXABIVAX SA | 135,800 | $15M | 2.2% | ADD 215% |
| 16 | VIRVIR BIOTECHNOLOGY INC | 1,498,620 | $13M | 1.9% | ADD 213% |
| 17 | HAEHAEMONETICS CORP | 220,672 | $12M | 1.8% | ADD 138% |
| 18 | SIONSIONNA THERAPEUTICS INC | 294,340 | $12M | 1.7% | NEW |
| 19 | SNYSANOFI SA | 239,671 | $12M | 1.7% | TRIM −75% |
| 20 | RAPPRAPPORT THERAPEUTICS INC | 366,809 | $11M | 1.7% | ADD 98% |
| 21 | TFXTELEFLEX INCORPORATED | 94,800 | $11M | 1.6% | ADD 9% |
| 22 | BMRNBIOMARIN PHARMACEUTICAL INC | 194,226 | $11M | 1.6% | TRIM −17% |
| 23 | CCRNCROSS CTRY HEALTHCARE INC | 1,098,393 | $10M | 1.5% | ADD 3% |
| 24 | TARAPROTARA THERAPEUTICS INC | 1,969,839 | $10M | 1.5% | ADD 15% |
| 25 | GPCRSTRUCTURE THERAPEUTICS INC | 209,093 | $10M | 1.5% | ADD 4% |
| 26 | BHVNBIOHAVEN LTD | 1,163,926 | $10M | 1.4% | TRIM −6% |
| 27 | MNPRMONOPAR THERAPEUTICS INC | 173,506 | $10M | 1.4% | NEW |
| 28 | EYPTEYEPOINT INC | 721,785 | $9M | 1.3% | NEW |
| 29 | CRNXCRINETICS PHARMACEUTICALS IN | 249,887 | $9M | 1.3% | ADD 100% |
| 30 | EWTXEDGEWISE THERAPEUTICS INC | 268,986 | $8M | 1.2% | ADD 13% |
| 31 | CMPSCOMPASS PATHWAYS PLC | 1,506,525 | $8M | 1.2% | NEW |
| 32 | OCULOCULAR THERAPEUTIX INC | 968,597 | $8M | 1.2% | NEW |
| 33 | AQSTAQUESTIVE THERAPEUTICS INC | 1,922,887 | $8M | 1.2% | ADD 94% |
| 34 | RLMDRELMADA THERAPEUTICS INC | 965,000 | $7M | 1.0% | NEW |
| 35 | ORKAORUKA THERAPEUTICS INC | 132,496 | $6M | 0.9% | ADD 12% |
| 36 | ZBIOZENAS BIOPHARMA INC | 331,730 | $6M | 0.9% | NEW |
| 37 | DRUGBRIGHT MINDS BIOSCIENCES INC | 86,083 | $6M | 0.9% | ADD 5% |
| 38 | QDELQUIDELORTHO CORP | 359,011 | $6M | 0.9% | NEW |
| 39 | ZBHZIMMER BIOMET HOLDINGS INC | 62,613 | $6M | 0.8% | TRIM −84% |
| 40 | REPLREPLIMUNE GROUP INC | 720,036 | $6M | 0.8% | NEW |
| 41 | OGNORGANON & CO | 865,908 | $5M | 0.7% | TRIM −75% |
| 42 | OKURONKURE THERAPEUTICS INC | 1,078,965 | $4M | 0.6% | NEW |
| 43 | IRONDISC MEDICINE INC | 65,203 | $4M | 0.6% | ADD 13% |
| 44 | PMVPPMV PHARMACEUTICALS INC | 3,076,580 | $4M | 0.5% | ADD 17% |
| 45 | IMNMIMMUNOME INC | 165,110 | $4M | 0.5% | NEW |
| 46 | IARTINTEGRA LIFESCIENCES HLDGS C | 383,140 | $4M | 0.5% | NEW |
| 47 | SVRASAVARA INC | 613,888 | $3M | 0.5% | HOLD |
| 48 | PRQRPROQR THRAPEUTICS N V | 1,954,715 | $3M | 0.5% | TRIM −10% |
| 49 | SISHOULDER INNOVATIONS INC | 210,641 | $3M | 0.4% | TRIM −8% |
| 50 | OVIDOVID THERAPEUTICS INC | 1,252,381 | $3M | 0.4% | TRIM −12% |
| 51 | KYMRKYMERA THERAPEUTICS INC | 32,235 | $3M | 0.4% | HOLD |
| 52 | ALGSALIGOS THERAPEUTICS INC | 327,237 | $2M | 0.4% | TRIM −3% |
| 53 | CNTXCONTEXT THERAPEUTICS INC | 917,922 | $2M | 0.3% | TRIM −32% |
| 54 | ANTXAN2 THERAPEUTICS INC | 657,200 | $2M | 0.3% | NEW |
| 55 | SERSERINA THERAPEUTICS INC | 1,000,000 | $2M | 0.3% | NEW |
| 56 | IBIOIBIO INC | 904,268 | $2M | 0.2% | ADD 22% |
| 57 | ADGMADAGIO MED HLDGS INC | 1,288,461 | $1M | 0.2% | HOLD |
| 58 | XLOXILIO THERAPEUTICS INC | 152,464 | $1M | 0.2% | NEW |
| 59 | BBOTBRIDGEBIO ONCOLOGY THERAPEUTIC | 130,628 | $1M | 0.2% | HOLD |
| 60 | HYPRHYPERFINE INC | 1,000,000 | $1M | 0.2% | TRIM −50% |
| 61 | SENSSENSEONICS HLDGS INC | 115,784 | $771,121 | 0.1% | HOLD |
| 62 | FHTXFOGHORN THERAPEUTICS INC | 122,889 | $587,409 | 0.1% | HOLD |
| 63 | TERNS PHARMACEUTICALS INC | 10,100 | $532,472 | 0.1% | HOLD |
| 64 | ENTAENANTA PHARMACEUTICALS INC | 40,000 | $505,200 | 0.1% | HOLD |
| 65 | TELATELA BIO INC | 636,300 | $394,506 | 0.1% | HOLD |
| 66 | NEUROONE MED TECHNOLOGIES CO | 496,614 | $385,621 | 0.1% | TRIM −56% |
| 67 | BOLDBOUNDLESS BIO INC | 163,679 | $180,047 | 0.0% | HOLD |
| 68 | NYXHNYXOAH S A | 50,839 | $148,450 | 0.0% | HOLD |
| 69 | MODDMODULAR MED INC | 26,190 | $138,283 | 0.0% | NEW |
| 70 | ERASERASCA INC | 5,000 | $80,900 | 0.0% | NEW |
| 71 | RCKTWWTS ROCKET PHARMACEUTICALS INC | 400,000 | $7,020 | 0.0% | HOLD |
| 72 | HUMAWHUMACYTE INC | 49,998 | $4,572 | 0.0% | HOLD |
| 73 | SLPSIMULATIONS PLUS INC | 200 | $2,364 | 0.0% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| MMSMAXIMUS INC | 381K | 468K | 548K | 558K | 500K | 769K | $49M |
| WAYWAYSTAR HLDG CORP | — | — | — | — | 614K | 1.6M | $40M |
| ICLRICON PLC | 196K | 203K | — | — | 127K | 306K | $34M |
| CORCENCORA INC | — | — | — | — | 16K | 101K | $32M |
| DNTHDIANTHUS THERAPEUTICS INC | — | 117K | 236K | 578K | 475K | 370K | $31M |
| AVRANTERIS TECHNOLOGIES GLOBAL | 2.4M | 2.4M | 1.8M | 1.8M | 1.9M | 5.4M | $30M |
| CORTCORCEPT THERAPEUTICS INC | — | — | — | — | — | 675K | $27M |
| LIVNLIVANOVA PLC | — | — | — | — | 322K | 422K | $27M |
| TYRATYRA BIOSCIENCES INC | 241K | 417K | 810K | 515K | 526K | 605K | $23M |
| CELCCELCUITY INC | — | — | — | 787K | 477K | 194K | $22M |
| GSKGSK PLC | — | — | — | 269K | — | 386K | $21M |
| ANIPANI PHARMACEUTICALS INC | 160K | 87K | 113K | 56K | 87K | 266K | $20M |
| ABTABBOTT LABS | — | — | — | — | — | 187K | $19M |
| EMBCEMBECTA CORP | 426K | 1.1M | 31K | — | — | 1.8M | $16M |
| ABVXABIVAX SA | — | — | — | — | 43K | 136K | $15M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.